Stryker Corporation
SYK
주식 순위
#192
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
주가
$304.21
시가총액
$116.69B
변동 (1일)
1.79%
변동 (1년)
-20.20%
국가
US
거래 Stryker Corporation (SYK)
카테고리
Healthcare
Stryker Corporation (SYK)의 수익
Jun 2026 기준 수익 TTM: $5.15B
Stryker Corporation의 최신 재무 보고서에 따르면 회사의 현재 수익은 $5.15B입니다. 2024년에 회사는 $3.49B의 수익을 올렸으며 이는 2023년의 수익 $3.67B과 감소입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Stryker Corporation의 수익 기록 (2000 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $5.15B | 14.05% |
| 2025 | $4.51B | 29.27% |
| 2024 | $3.49B | -4.93% |
| 2023 | $3.67B | 36.90% |
| 2022 | $2.68B | 17.62% |
| 2021 | $2.28B | 16.73% |
| 2020 | $1.95B | -23.73% |
| 2019 | $2.56B | 8.74% |
| 2018 | $2.36B | 14.20% |
| 2017 | $2.06B | 7.39% |
| 2016 | $1.92B | 10.72% |
| 2015 | $1.74B | 49.57% |
| 2014 | $1.16B | -4.29% |
| 2013 | $1.21B | -28.91% |
| 2012 | $1.71B | 1.13% |
| 2011 | $1.69B | -2.52% |
| 2010 | $1.73B | 6.51% |
| 2009 | $1.62B | 2.77% |
| 2008 | $1.58B | 15.33% |
| 2007 | $1.37B | 24.13% |
| 2006 | $1.10B | 10.02% |
| 2005 | $1.00B | 39.93% |
| 2004 | $717.00M | 9.89% |
| 2003 | $652.50M | 28.77% |
| 2002 | $506.70M | 24.90% |
| 2001 | $405.70M | 21.14% |
| 2000 | $334.90M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $7.51B | 45.90% |
US
|
|
| $5.56B | 8.06% |
IE
|
|
| $3.86B | -25.00% |
US
|
|
| - | - |
DE
|
|
| $1.42B | -72.46% |
US
|
